B.A., University of New Hampshire, Zoology, 1973
M.A., University of Montana, Zoology, 1977
Ph.D., University of Washington, Biostatistics, 1984.
Dr. Storer works to optimally design clinical trials, including Phase III (randomized controlled trials of efficacy), Phase II (uncontrolled trials of efficacy, often with surrogate endpoints) and Phase I (dose-finding trials evaluating toxicity), especially using non-standard designs that might be advantageous with particular trial objectives. He has also focused on developing statistical methods that can identify patient, disease and treatment variables that significantly impact disease incidence and severity and/or outcomes with particular therapies.